The maximum expression of the gene was achieved by coexpression of IRF-1 and PU.1 in HEK293 cells and IRF-2 suppressed the IRF-1-mediated enhancement of gene expression, suggesting that
Trang 1aminopeptidase/endoplasmic reticulum-aminopeptidase 2 gene by interferon-c
Toshihiro Tanioka1,*, Akira Hattori1, Shigehiko Mizutani2 and Masafumi Tsujimoto1
1 Laboratory of Cellular Biochemistry, RIKEN, Wako, Saitama, Japan
2 Department of Obstetrics and Gynecology, Nagoya University School of Medicine, Showa, Nagoya, Japan
Keywords
aminopeptidase; antigen-presentation;
interferon regulatory factor; interferon-c;
PU.1
Correspondence
M Tsujimoto, Laboratory of Cellular
Biochemistry RIKEN (The Institute of
Physical and Chemical Research), 2-1
Hirosawa, Wako-shi, Saitama 351-0198
Japan
Fax: +81 48 462 4670
Tel: +81 48 467 9370
E-mail: tsujimot@riken.jp
*Present address
Laboratory of Medical Information, Showa
University School of Pharmaceutical
Sciences, Shinagawa, Tokyo 142-8555,
Japan
Note
The nucleotide sequence of human
L-RAP(s)1 and L-RAP(s)2 reported in this
paper have been submitted to the
GenBankTM⁄ EMBL ⁄ DDBJ Data Bank with
accession numbers AY028805 and
AB163917, respectively.
(Received 12 October 2004, revised 26
November 2004, accepted 8 December
2004)
doi:10.1111/j.1742-4658.2004.04521.x
The leukocyte-derived arginine aminopeptidase (L-RAP) is the second ami-nopeptidase localized in the endoplasmic reticulum (ER) processing anti-genic peptides presented to major histocompatibility complex (MHC) class
I molecules In this study, the genomic organization of the gene encoding human L-RAP was determined and the regulatory mechanism of its expres-sion was elucidated The entire genomic structure of the L-RAP gene is similar to both placental leucine aminopeptidase (P-LAP) and adipocyte-derived leucine aminopeptidase(A-LAP) genes, confirming the close relation-ship of these three enzymes Interferon (IFN)-c up-regulates the expression
of the L-RAP gene Deletion and site-directed mutagenic analyses of the 5¢-flanking region of the L-RAP gene and electrophoretic mobility shift assay indicated that while interferon regulatory factor (IRF)-2 is important
in the basal condition, IRF-1 is the primary regulator of IFN-c-mediated augmentation of the gene expression In addition, PU.1, a member of the E26 transformation-specific family of transcription factors, also plays a role
in the regulation of gene expression The maximum expression of the gene was achieved by coexpression of IRF-1 and PU.1 in HEK293 cells and IRF-2 suppressed the IRF-1-mediated enhancement of gene expression, suggesting that IFN-c-induced L-RAP gene expression is cooperatively regulated by IRFs and PU.1 transcription factors
Abbreviations
A-LAP, adipocyte-derived leucine aminopeptidase; BAC, bacterial artificial chromosome; CHX, cycloheximide; DTT, dithiothreitol; EMSA, electrophoretic mobility shift assay; ER, endoplasmic reticulum; ERAP, endoplasmic reticulum aminopeptidase; Ets, E26 transformation-specific; IFN, interferon; IL, interleukin; IRF, interferon regulatory factor; L-RAP, leukocyte-derived arginine aminopeptidase; MHC, major histocompatibility complex; P-LAP, placental leucine aminopeptidase; PMSF, phenylmethanesulfonyl fluoride; TAP, transporter associated with antigen processing.
Trang 2Aminopeptidases hydrolyze N-terminal amino acids of
proteins or peptide substrates They are distributed
widely in animal and plant tissues as well as in bacteria
and fungi, suggesting that they play important roles in
various biological processes [1] Among them, M1
zinc-metallopeptidases (gluzincins) share the consensus
GAMEN and HEXXH(X)18E zinc-binding motifs
essential for enzymatic activity [2,3] So far, nine
enzymes belonging to the family were identified and
laeverin was recently reported as the tenth member
although its enzymatic activity was not reported [4,5]
In our previous work, we cloned a cDNA for the
pla-cental leucine aminopeptidase (P-LAP)⁄ oxytocinase, a
type II membrane-spanning protein which belongs to
the M1 family of aminopeptidases [6] Subsequently we
cloned cDNAs encoding adipocyte-derived leucine
aminopeptidase (A-LAP) [7], which is also designated as
puromycin-insensitive leucine-specific aminopeptidase
(PILS-AP) or ER-aminopeptidase (ERAP)-1 [8,9], and
leukocyte-derived arginine aminopeptidase (L-RAP)⁄
ERAP2 [4] as highly homologous proteins to P-LAP
Structural and phylogenetic analyses indicated the close
relationship between these three enzymes Therefore we
proposed that they should be classified into the
oxyto-cinase subfamily of M1 aminopeptidases [10]
Recent evidence facilitates new insights into the
biological significance of the oxytocinase subfamily
of aminopeptidases P-LAP⁄ oxytocinase, which is
also designated as insulin-regulated aminopeptidase
(IRAP), was shown to translocate from the
intracellu-lar compartment to the plasma membrane in a
stimu-lus-dependent manner and may regulate concentration
of substrate peptide hormones on the cell surface
[11–14] This enzyme was recently shown to be the
angiotensin IV receptor and may play a role in
memory retention and retrieval [15,16] On the other
hand, we and others reported that A-LAP⁄ ERAP1 is a
final processing enzyme of the precursors of the major
histocompatibility complex (MHC) class I-presented
antigenic peptides [9,17] A-LAP⁄ ERAP1 was also
shown to play roles in blood pressure regulation and
angiogenesis [18–20] Moreover, the enzyme was shown
to bind to cytokine receptors such as tumour necrosis
factor type I receptor, interleukin (IL)-6 a-receptor
and IL-1 type II receptor, and facilitate ectodomain
shedding of these receptors [21–23] As for
L-RAP⁄ ERAP2, we have shown that the enzyme is
retained in the endoplasmic reticulum (ER) and can
trim some precursor peptides to MHC class I ligands
[4] These results indicate that the mammalian
amino-peptidases belonging to the oxytocinase subfamily play
important roles in the regulation of several biological
processes
Precursors of MHC class I-presented peptides with extra N-terminal residues are trimmed to mature epi-topes in the ER [24,25] The peptides are first cleaved from endogenously synthesized proteins by proteasome
or tripeptidyl peptidase II in the cytoplasm, transpor-ted into ER-lumen and then trimmed by certain aminopeptidases Until now, only two aminopeptid-ases (A-LAP⁄ ERAP1 and L-RAP ⁄ ERAP2) have been identified in the ER-lumen and have shown their ability to trim antigenic peptides [4,9,17] Characteris-tically, as in the case of other components included in the presentation of MHC class I ligands such as MHC class I molecules, transporter associated with antigen processing (TAP) and proteasome b-subunits, inter-feron (IFN)-c enhances the expression of these enzymes [24] Although IFN-c-inducible aminopeptid-ases including lens LAP, A-LAP, and L-RAP play roles in the processing or degradation of antigenic peptides [4,9,17,26], the mechanisms of IFN-c-medi-ated regulation of aminopeptidase gene expression have never been examined
In the current study, we have elucidated the genomic structure of human L-RAP gene for the first time Characterization of the promoter region of the gene indicates that while interferon regulatory factor
(IRF)-2 is important in the basal condition, IRF-1 is the primary regulator of IFN-c-mediated augmentation of the gene expression It is also shown that PU.1, a member of the E26 transformation-specific (Ets) family
of transcription factors, plays a role in the regulation
of gene expression Our data provide the molecular basis of regulatory mechanisms of enzymatic activity
of L-RAP, which may play an important role in the processing of antigenic peptides presented to MHC class I molecules in the ER
Results
Genomic organization of human L-RAP gene
To elucidate the genomic organization of the L-RAP gene, we screened a human genome database prepared
in a bacterial artificial chromosome (BAC) This led to the identification of BAC clone RPCI-11-496M2 (accession number AC009126), which contains all exons of the L-RAP gene All exons and intron–exon junctions were determined from the database The sequences of splice junctions obey the GT-AG rule [27] As shown in Fig 1, the gene spans 45 kb and contains 19 exons ranging in size from 28 bp (exon 1)
to 697 bp (exon 2) and the overall structure of the gene is quite similar to both P-LAP and A-LAP genes The first exon includes only the 5¢-untranslated region
Trang 3Exon 2 includes the remaining 5¢-untranslated region
and coding sequence for the first 192 amino acids The
GAMEN and HEXXH motifs are encoded in exon 6
and an essential glutamic acid residue located 19
amino acids downstream from the HEXXH motif is
encoded in exon 7 Exon 19 contains the coding
sequence for the last 47 amino acids, stop codon
(TAA) and the 3¢-untranslated region
In our previous work, we obtained a cDNA
enco-ding the truncated form of L-RAP [4] Exon 10 that is
deleted in the P-LAP gene encodes a sequence that
may function as a hinge region [28] As shown in
Fig 1, a transcript encoding this form, termed
L-RAP(s)1 (accession number AY028805), is generated
by differential usage of exon 10 When an intermediate
nucleotide sequence (AACATGgtaag) matching the
GT-AG rule in the exon functions as a splicing donor,
full length L-RAP transcript is generated If the
sequence does not act as a splicing donor, the stop
codon (TGA) in the exon causes the generation of
a truncated form Thereafter, another transcript,
L-RAP(s)2 (accession number AB163917), encoding
the same truncated form was also cloned Differential
usage of exon 15 causes the generation of two
trun-cated forms of the transcripts These results indicate
that at least three mRNAs encoding either the full
length or truncated form of L-RAP protein are
gener-ated from a single gene
Isolation and characterization of human L-RAP
gene promoter
Figure 2 shows the nucleotide sequence of the
5¢-flank-ing region of the human L-RAP gene The
transcrip-tional initiation site of the gene was determined by
5¢ RACE and is shown as nucleotide position +1
in the figure The site (TCAGTC) matches well with
the pyrimidine-rich initiator consensus sequence,
PyPy(A+1)N(T⁄ A)PyPy, in which Py represents a
pyrimidine residue [29] Computer analysis of the
sequence revealed no canonical TATA- or CCAAT-box, suggesting a housekeeping nature for the gene On the other hand, several potential transcription factor binding motifs, such as IRF, GATA-1, Sp-1 and AP-1 were identified in the promoter region of the gene [30]
To characterize the regions regulating transcriptional activity of the L-RAP gene, chimeric reporter plasmids encoding the luciferase gene and different lengths of L-RAP gene were constructed The resultant chimeric constructs were then transfected into HEK293 cells to analyze the promoter activity As a negative control, the promoter-less pGL3 basic plasmid was transfected into the cells As shown in Fig 3A, substantial promo-ter activity was detected when chimeric constructs con-taining the 5¢-flanking sequence upstream from the A
at position )10 were transfected, confirming that the 5¢-flanking sequence of the L-RAP gene is indeed able
to support transcriptional initiation The maximum
Fig 1 Genomic structure of the human L-RAP gene Schematic exon–intron structure of the gene is shown at the center Exons are numbered and depicted as boxes Asterisks indicate the sites used for the generation of different mRNAs described in the text Generation scheme of L-RAP and L-RAP(s) proteins is also shown in the figure Numbers shown in each protein molecule are number of amino acids derived from the respective exons.
Fig 2 Nucleotide sequence of the 5¢-flanking region of the human L-RAP gene The 5¢-flanking region was searched for transcription factor binding sites by TF - SEARCH The exon sequence is shown in uppercase letters, while that of the untranscribed region is given in lowercase letters The transcriptional initiation site shown as +1 was determined by 5¢-RACE For the measurement of promoter activity, the start point of each construct is indicated by an arrowhead.
Trang 4promoter activity was obtained with the constructs
containing the sequence from)33 to +5 Deletion of
the sequence from)33 to )17 caused a decrease in the
promoter activity by nearly 50% Further deletion to
T at position )9 caused almost complete loss of
activ-ity Employing Jurkat-T cells, we obtained nearly the
same results
The promoter sequence from)33 to )17 contains a sequence (AGAAAGTGAAAGC) with resemblance to the IRF-E consensus sequence [G(A)AAASYGAA ASY] We next examined the role of this site on the basal promoter activity by constructing mutant plasmid [phLP5(MuI)] from phLP5 plasmid We describe this sequence as the IRF-E site hereafter [31]
Fig 3 Role of the IRF-E site in IFN-c-induced enhancement of L-RAP gene expression in HEK293 cells (A) Luciferase expression plasmids (1 lg) containing sequentially deleted fragments of the L-RAP chimera were transfected into HEK293 cells Luciferase activity was measured
as described in Experimental procedures and normalized to the b-galactosidase activity of a cotransfected internal control plasmid The luci-ferase activity obtained in the basal condition from cells transfected with phLP1 was taken as 100% (B) Enhancing effect of IFN-c is shown
by fold increase in the figure (C) Functional analysis of the IRF-E site of the L-RAP gene promoter in HEK293 cells The phLP5 plasmid hav-ing either an intact or mutated IRF-E site was transfected into HEK293 cells and the luciferase activity was measured as described above Open bars indicate luciferase activity in the basal condition and closed bars in the IFN-c-stimulated condition.
Trang 5Although substantial activity was retained, mutation
of the IRF-E site caused a significant decrease in the
promoter activity (Fig 3C) These results suggest that
the IRF-E site is crucial for the maximum promoter
activity of the L-RAP gene in the basal condition
Mechanism of IFN-c-mediated regulation
of L-RAP gene expression
Because L-RAP gene expression is enhanced by IFN-c,
we next examined its regulatory mechanism As an
ini-tial experiment, decay rates of L-RAP mRNAs
pre-pared from Jurkat-T cells treated with or without
IFN-c were compared in the presence of actinomycin
D As shown in Fig 4A, there was little difference
between decay rates of L-RAP mRNAs in the cells
treated with or without IFN-c, indicating that the
cytokine-induced enhancement of mRNA
accumula-tion could not be attributed to the change of stability
of L-RAP mRNA In addition, it was found that the
increase in mRNA accumulation was not observed in
the presence of cycloheximide (CHX), indicating that
de novo protein synthesis was required for the action
of IFN-c (Fig 4B)
To elucidate the role of IFN-c in the regulation of
L-RAP gene expression, the luciferase-reporter assay
was conducted to identify cytokine responsive elements
in the gene As shown in Fig 3A,B, IFN-c induced
about a fourfold increase in the expression of
luci-ferase activity in HEK293 cells transfected with
con-structs containing the sequence from)33 to )17 After
deletion of this sequence, IFN-c had no enhancing
activity These results indicate that the sequence is
essential for the cytokine-induced increase in L-RAP
gene expression
Because the sequence from )33 to )17 contains the
IRF-E site, we next examined the role of this site in
L-RAP gene regulation As shown in Fig 3C,
muta-tion in this site caused complete loss of IFN-c-induced
increase in the luciferase activity, confirming the role
of the IRF-E site in the cytokine-mediated L-RAP
gene regulation These results indicate that the IRF-E
site plays an important role both in the basal and
IFN-c-mediated L-RAP gene expression
On the other hand, it was found that in addition to
the IRF-E site, the Ets site in the promoter also plays
a role in gene expression in Jurkat-T cells As in the
case of HEK293 cells, the IRF-E site was required for
the maximum expression of the gene IFN-c induced
an eightfold increase in the gene expression in cells
transfectied with phLP5 plasmid When Jurkat-T cells
were transfected with plasmids containing the sequence
from )67 to )33 that contains the Ets site, a further
increase (about 13- to 15-fold) was observed (Fig 5A,B) Mutation of either the IRF-E [phLP4(MuI)] or Ets site [phLP4(MuE)] caused a substantial decrease in the IFN-c-mediated gene expression Plasmid having mutations in both sites [phLP4(MuE⁄ MuI)] had little activity, indicating that
in Jurkat-T cells both the IRF and Ets sites are required for maximum enhancement of IFN-c-induced gene expression (Fig 5C) In contrast, it was found that the Ets site had no effect on the promoter activity
in HEK293 (data not shown) We found by RT-PCR
A
B
Fig 4 Requirement of de novo protein synthesis for IFN-c-medi-ated enhancement of L-RAP gene expression (A) Effect of IFN-c
on the stability of L-RAP mRNA Jurkat-T cells were treated with or without 30 ngÆmL)1IFN-c for 12 h at 37 C and further incubated in the presence of 1 l M actinomycin D (ActD) for indicated times After incubation, expression levels of L-RAP mRNAs were meas-ured by Northern blot analysis Densitometric data showing the decay rates of mRNAs are also shown (B) Effect of CHX on the IFN-c-induced enhancement of L-RAP gene expression Jurkat-T cells were preincubated for 3 h in the presence or absence of
1 lgÆmL)1 cycloheximide (CHX) and further incubated with
30 ngÆmL)1IFN-c for 12 h at 37 C L-RAP mRNAs were detected
by Northern blot analysis.
Trang 6that expression of PU.1 was detectable in Jurkat-T
cells but not in HEK293 cells (data not shown)
Although the Oct-1 site is located proximal to the
Ets site, mutational analysis indicated that this site
had little effect on the gene expression (data not
shown)
Role of IRFs in the regulation of L-RAP gene expression
Transcription factors, IRF-1 and -2 are known to bind
to the IRF-E site and regulate IFN-c action [31] To examine whether IFN-c affects the expression levels of
Fig 5 Role of the IRF-E and Ets sites in IFN-c-induced enhancement of L-RAP gene expression in Jurkat-T cells (A) Luciferase expression plasmids (10 lg) containing sequentially deleted fragments of the L-RAP chimera were transfected into Jurkat-T cells Cells were then trea-ted with or without 30 ngÆmL)1IFN-c for 15 h at 37 C Luciferase activity was measured as described in Experimental procedures and nor-malized to the b-galactosidase activity of a cotransfected internal control plasmid The luciferase activity obtained in the basal condition from cells transfected with phLP1 was taken as 100% (B) Enhancing effect of IFN-c is shown by fold increase in the figure (C) Mutational analy-sis of the IRF-E and Ets sites of the L-RAP gene promoter in Jurkat-T cells The phLP4 plasmid having either intact or mutated sites shown
in the left panel of the figure was transfected into Jurkat-T cells and luciferase activity was measured Open bars indicate luciferase activity
in the basal condition and closed bars in the IFN-c-stimulated condition.
Trang 7IRF-1 and -2 proteins, HEK293 cells were cultured in
the presence or absence of the cytokine (Fig 6A)
When compared with untreated cells, an increase in the
expression level of IRF-1 was observed in cells treated
with IFN-c, indicating that IRF-1 is a candidate for the
mediator of IFN-c action In contrast, no effect was
observed on the expression of IRF-2 protein
To determine whether IRF-1 and -2 bind to the
IRF-E site in the L-RAP promoter sequence, we
per-formed an electrophoretic mobility shift assay (EMSA)
using nuclear extracts from HEK293 cells treated with
or without IFN-c (Fig 6B) An oligonucleotide probe corresponding to the IRF-E site bound to nuclear extracts prepared from both IFN-c-treated and untreated cells In spite of the presence of an unex-pected nonspecific large band, bands shown as IRF-1 and -2 in Fig 6 were replaced by unlabeled oligo-nucleotide competitor, indicating their specificity The specificity of these bands was also confirmed by oligo-nucleotide with mutations at the IRF-E site Although repeated trials were made, we could not remove the nonspecific bands
To identify transcription factors bound to the
IRF-E site, supershift assay was performed using antibodies raised against IRF-1 and IRF-2 When anti-(IRF-1) IgG was employed, supershift was observed only in the IFN-c-treated cells On the other hand, anti-(IRF-2) IgG caused supershift in both treated and untreated cells Moreover, appearance of two supershift bands and complete disappearance of the oligonucleotide spe-cific bands was observed in the presence of both anti-bodies These results suggest that while in untreated cells IRF-2 but not IRF-1 was bound to the IRF-E site, IRF-1 and IRF-2 co-occupied the site after treat-ment with IFN-c We obtained the same results in Jur-kat-T cells However, it should be noted here that an IFN-c-inducible band other than IRF-1 and -2 was also observed in this experiment, suggesting that tran-scription factors other than IRF-1 and -2 also partici-pate in the regulation of L-RAP gene expression
A
B
Fig 6 Role of IRF-1 and PU.1 in the expression of the L-RAP gene (A) IFN-c-induced increase in the expression of IRF-1 protein in HEK293 cells HEK293 cells were treated with or without
30 ngÆmL)1IFN-c for 5 h at 37 C IRF-1 and IRF-2 in the nuclear extracts were measured by Western blot analysis (B) Binding of IRF-1 and IRF-2 to the IRF-E site of the L-RAP gene HEK293 cells were treated with or without 30 ngÆmL)1 IFN-c for 5 h at 37 C EMSAs were then performed in nuclear extracts using a probe con-taining the IRF-E site from the L-RAP gene promoter Supershifts were conducted using antibodies against indicated factors Arrow-heads indicate the positions of IRF-1 and IRF-2 Arrow indicates the position of unidentified IFN-c-inducible IRF-E binding protein Lanes shown as probe are loaded only with labeled probe (C) Enhance-ment of promoter activity of the L-RAP gene by transcription fac-tors HEK293 cells were cotransfected with phLP4 (0.5 lg) and various expression plasmids (0.5 lg) shown in the figure After
24 h, luciferase activity was measured as described in Experimental procedures Enhancing effects of the transcription factors are shown by fold increase using cells transfected only with phLP4 or
as a control (D) Induction of endogenous L-RAP gene expression
by transcription factors HEK293 cells were transfected with expression plasmids (0.5 lg) shown in the figure For RT-PCR ana-lysis, total RNA was extracted after 24 h-incubation Relative expression level is shown by fold increase in the figure using mock-transfected cell as a control.
Trang 8To further elucidate the role of IRF-1 and -2 in the
regulation of L-RAP gene expression, phLP4 plasmid
was cotransfected either with pTARGET-IRF-1 or
pTARGET-IRF-2 plasmid into HEK293 cells
(Fig 6C) IRF-1 overexpressed in HEK293 cells
induced 8.6-fold increase in the luciferase activity,
indi-cating that IRF-1 is indeed able to augment L-RAP
gene expression IRF-2 and PU.1, a transcription
fac-tor which is known to bind to the Ets site [32], also
had enhancing effects on the luciferase activity, and a
4.7- and 2.1-fold increase in the gene expression was
observed, respectively Furthermore, maximum gene
expression (18.3-fold increase) was achieved in a
syner-gistic manner when IRF-1 and PU.1 were coexpressed
On the other hand, coexpression of IRF-1 and IRF-2
caused lower expression of luciferase activity than
expected, suggesting that IRF-2 suppressed
IRF-1-mediated augmentation of the gene expression We
also examined other Ets site-binding factors such as
Ets-1 and Ets-2 and found that they had little effect
on the gene expression (data not shown) When the
same experiments were performed using either
phLP4(MuE), phLP4(MuI) or phLP4(MuE⁄ MuI), no
synergistic effect between IRF-1 and PU.1 was
observed (data not shown), confirming that native sites
of both IRF-E and PU.1 are required for the
synergis-tic action Taken together these results indicate that
while IRF-2 plays a role in the basal condition, IRF-1
can mediate IFN-c-stimulated L-RAP gene expression
synergistically with PU.1
To determine whether IRF-1 indeed mediates
L-RAP gene expression in vivo, we next examined the
effect of transcription factors on the expression of
endogenous L-RAP gene Several combinations of
plasmids were transfected into HEK293 cells and their
ability to enhance gene expression was examined by
RT-PCR (Fig 6D) In mock-transfected cells, L-RAP
mRNA was barely detectable Among trancription
fac-tors tested, the highest expression was achieved when
IRF-1 was overexpressed Further increase in the gene
expression was observed when IRF-1 and PU.1 were
coexpressed In contrast, IRF-2 suppressed
IRF-1-mediated increase in the gene expression, although
IRF-2 alone had some enhancing activity These
results further confirm the roles of transcription factors
in the expression of the L-RAP gene
Discussion
L-RAP⁄ ERAP2 is a newly identified ER
aminopepti-dase and the third member of the oxytocinase
sub-family of M1 sub-family of aminopeptidases [4] It was
suggested by its ability to generate certain antigenic
peptides that the enzyme plays an important role in the processing of antigenic peptides presented to MHC class I molecules in the ER In this study, we deter-mined the genomic structure of the human L-RAP gene and characterized the regulatory mechanisms of the gene expression It was found that two forms of the L-RAP proteins are generated by alternative spli-cing While the full length form exerts distinct amino-peptidase activity, the truncated form has no enzymatic activity [4] It is necessary to elucidate the relationship between these two forms
The entire genomic structure of the L-RAP gene is quite similar to the P-LAP and A-LAP genes [28,33] The GAMEN and HEXXH(X)18E motifs essential for the enzymatic activity are encoded by exons 6 and 7
of the respective genes Becasue these three genes are located contiguously around human chromosome 5q15, between versican and calpastatin [28], these data further confirm the latest divergence of the genes from
a common ancestral gene
Expression of L-RAP is up-regulated by IFN-c [4] IFN-c also stimulates the induction of components included in the processing of MHC class-I ligands [24] Considering the evidence that suggest a role of L-RAP
as an antigen-trimming enzyme in the ER, it is import-ant to elucidate the mechanism of the IFN-c-induced increase in L-RAP gene expression The transient expression of the 5¢-flanking region of the L-RAP gene fused to the luciferase gene in either HEK293 or Jurkat-T cells allowed the analysis of basal and IFN-c-mediated regulation of promoter activity We demon-strated by deletion analysis that the sequence ranging from )16 to )10 carries the minimum promoter activ-ity of the gene In addition, mutational analysis sug-gested that the IRF-E site is required for the maximum enhancement of gene expression in the basal condition Because EMSA indicated that IRF-2 is associated with the IRF-E site in unstimulated HEK293 cells, our data suggest that IRF-2 can aug-ment the transcription of the L-RAP gene in the basal condition In fact, IRF-2 had some enhancing effect
on the gene expression when overexpressed in HEK293 cells Although it is generally considered that IRF-2 is
a negative regulator of gene expression [31], it has also been shown to up-regulate the expression of several genes such as histone 4 and VCAM-1 [34,35] However,
we could not completely rule out the possible contribu-tion of other IRF-E site-binding proteins [31], because
an IFN-c-inducible IRF-E binding protein other than IRF-1 and IRF-2 was detectable by EMSA, even in the basal condition Identification and elucidation of the role of this protein in L-RAP gene expression is required
Trang 9It is worthy of noting here that both P-LAP and
A-LAP promoters also contain IRF-E sites [28,33] It
was reported that IFN-c had no enhancing effect on
P-LAPgene expression [33] In our preliminary results,
the IRF-E site in the A-LAP promoter had little effect
on IFN-c-induced gene expression, raising the
possib-lity that IFN-c affects the expression of the A-LAP
gene differently from that of the L-RAP gene
IFN-c-induced increase in L-RAP gene expression
required de novo protein synthesis and it was found
that IRF-1 was induced by IFN-c Deletion and
muta-tional analyses indicated that the IRF-E site is
res-ponsible for the cytokine-mediated increase in gene
expression in HEK293 cells Mutation of the site
caused loss of the cytokine action EMSA indicated
that while IRF-2 but not IRF-1 bound to the IRF-E
site in the basal condition, binding of both IRF-1 and
-2 were detectable after treatment with IFN-c
More-over, transfection of the IRF-1 expression plasmid
into HEK293 cells caused an increase in the gene
expression These results strongly suggest that IRF-1 is
a primary mediator of IFN-c-mediated enhancement
of L-RAP gene expression in HEK293 cells Because
coexpression of IRF-1 and IRF-2 caused a decrease in
L-RAP gene expression, it is plausible that IRF-2 acts
as a negative regulator of IRF-1-mediated
enhance-ment of gene expression, by co-occupation of the
IRF-E site with IRF-1 in IFN-c-treated cells
On the other hand, the mechanism of IFN-c-induced
L-RAPgene regulation in Jurkat-T cells is rather
com-plex It is obvious that in addition to the IRF-E site,
the Ets site located between )63 and )56 also plays a
role in the maximum enhancement of IFN-c-induced
gene expression It is unlikely that another Ets site
located between )352 and )345 plays a role in the
gene expression, because deletion of this sequence had
little effect on the enhancement of the gene expression
Among the Ets family transcription factors tested, only
PU.1 could mediate the cytokine action The
expres-sion of PU.1 is limited to hematopoietic lineages and
is necessary for the differentiation of myeloid cell
line-ages such as macrophline-ages and osteoclasts [36,37] Our
analysis by RT-PCR indicated the expression of PU.1
in Jurkat-T cells but not HEK293 cells Therefore, it is
plausible that the lineage-dependent expression of
PU.1 may determine the expression level of the L-RAP
gene Consistent with this notion, IRF-1 and PU.1
mediated the maximum expression of both reporter
and endogenous genes when overexpressed, even in
HEK293 cells
The molecular basis of the cooperative action of
transcription factors is considered to be the physical
interaction of the transcription factors involved [37]
For instance, it was reported that IRFs and PU.1 synergistically mediate the transcriptional enhancement
of human interleukin-1 (IL-1)b gene expression It was
suggested by physical interaction analysis that the fac-tors might function together as an enhanceosome [38]
As shown in other genes [39,40], it is plausible that IRF-1 mediates the IFN-c-stimulated L-RAP gene expression through interaction with PU.1 On the other hand, it is possible that IRF-2 acts independently from PU.1 to enhance the gene expression in the basal con-dition Because binding of IRF-2 to the IRF-E site was still observed after IFN-c treatment, it is possible to speculate that IRF-2 modulates the gene expression by interacting with IRF-1 in the IRF-E site of the L-RAP gene As with the L-RAP gene, Gobin et al reported that binding of IRF-2 to the MHC class I molecule promoter was observed after IFN-c treatment [41] It was also reported that IRF-2 co-occupies the IRF-E site of the class II transactivator type IV promoter with IRF-1 and synergistically activates the promoter [42] L-RAP⁄ ERAP2 is the second ER-lumenal amino-peptidase to be determined, and can trim certain pre-cursors of antigenic peptides presented to MHC class I molecules [4], suggesting the potential significance of this enzyme in antigen processing In this study, we characterized the L-RAP gene for the first time We have shown that the IRF-E site located in the proximal region of the transcription initiation site plays a pivotal role in the regulation of human L-RAP gene expres-sion both in the basal and IFN-c-stimulated condi-tions As shown in several genes [43–45], it was found that while IRF-2 plays a role in the basal condition, IRF-1 is the primary regulator of the gene expression induced by IFN-c However, transcription factor(s) other than IRF-1 and -2 may also regulate L-RAP gene expression Further works are required to exam-ine the involvement of other transcription factors that bind to the IRF-E site Considering the significance of the processing of antigen presented to MHC class I molecules in several pathophysiological conditions such
as virus infection, tumor generation and self-antigen generation, it is important to elucidate the total aspects
of the antigen presentation process including the regu-latory mechanisms of L-RAP gene expression
Experimental procedures
Identification of the human L-RAP gene
A genomic sequence of 178 kb from the Gen-BankTM⁄ EMBL ⁄ DDBJ Data Bank was obtained This sequence encompasses a region on human chromosome 5q15 where the known P-LAP gene is located The
Trang 10loca-tions of the exons of the L-RAP gene were determined
using the blast program
Cell culture
Jurkat-T cells were obtained from the RIKEN Cell Bank
(Tsukuba, Japan) and maintained in RPMI 1640 Human
embryonic kidney (HEK) 293 cells were purchased from
ATCC (Manassas, VA, USA) and maintained in RPMI
1640 All media used in this study was from Sigma (St
Louis, MO, USA) and supplemented with 10% fetal
bovine serum (JRH Biosciences, Lenexa, KS, USA),
peni-cillin G, and streptomycin (Meiji Seika Co., Kanagawa,
Japan) The cells were cultured in a humidified 5% CO2
and 95% air incubator at 37C
Analysis of promoter activity
The human L-RAP 5¢-flanking region and its fragments,
which include the transcriptional initiation site, were
amplified by PCR from a BAC clone PCR products
were inserted into the promoter-less plasmid, pGL3 basic
(Promega, Madison, WI, USA) The nucleotide sequence
of the primers used for PCR amplification were as
follows (5¢-3¢): CGGGTACCTGAACCAGCTAGTACT
TACTG (sense strand of the sequence from )88 to )68)
for phLP3; CGGGTACCTACTCAGGAAGCATGC
AAGT (sense strand of the sequence from )67 to )47)
for phLP4; CGGGTACCACAGAAAGTGAAAGCA
(sense strand of the sequence from )33 to )18) for
phLP5; CGACGCGTTGACTGAAGGGGAATTTACTTT
(antisense strand of the sequence from )17 to +5) for
all constructs For phLP6 and 7, plasmids were
construc-ted by using synthetic oligonucleotides corresponding to
the 5¢-flanking region We also constructed phLP1 and
2 plasmids by sequetial deletion of SmaI and Van91I
fragment from phLP0 covering the sequence from )1042
to +5
Mutagenesis of the IRF and Ets sites was performed
by using mutated oligonucleotides when constructing
the respective plasmids For making mutations in IRF,
5¢-CACAGAGGGTGAGGGCAAAAGTAAATTCCCCTT
CAGTCAA-3¢ (sense sequence of mutant IRF-E site) and
5¢-CGCGTTGACTGAAGGGGAATTTACTTTTGCCCT
CACCCTCTGTGGTAC-3¢ (antisense sequence of mutant
IRF-E site) were used For the Ets mutant, 5¢-GGGGTA
CCTACTCAAAGAGCATGCAAAGT-3¢ (sense sequence
of mutant Ets site) and 5¢-CGACGCGTTGACTGAAGG
GGAATTTACTTT-3¢ (antisense sequence of mutant Ets
site) were used For the construction of the double mutant
plasmid, 5¢-GGGGTACCTACTCAAAGAGCATGCAAA
GT-3¢ and 5¢-CGACGCGTTGACTGAAGGGGAATTTA
CTTTTGCCCTCACCCTCTGTTCTAA-3¢ (antisense
sequ-ence of mutant IRF-E site) were used The mutated
nucleo-tide sequences are underlined
The PU.1 expression plasmid pcDNA3-PU.1 which was constructed by using pcDNA3 (Invitrogen, Carlsbad, CA, USA) was obtained from M Matsumoto of Saitama Med-ical School (Saitama, Japan) [46]
Transfection and luciferase assay For transfection of the reporter plasmid, HEK293 cells were plated on 24 well plates at a density of 1· 105 cells per well on the day before transfection, while Jurkat-T cells (1· 106 cells) were plated in a 100 mm dish Plasmid DNA was mixed with LipofectAmine (Invitorogen) and transfected into HEK293 cells following the manufacturer’s protocol A pCMVb (0.5 lg) plasmid was employed as an internal control of transfection efficiency To transfect into Jurkat-T cells, the electroporation (225 V, 350 lF) method was employed, using Electro Cell Manipulator (BTX, San Diego, CA, USA) After 24 h of transfection, the cells were washed three times with NaCl⁄ Piand then lysed in reporter lysis buffer (Promega) The luciferase activity was then measured with a luciferase assay system (Promega) accord-ing to the manufacturer’s instruction Luciferase activity was measured in triplicate, averaged, and then normalized
to b-galactosidase activity to correct for transfection effi-ciency b-Galactosidase activity was measured using o-nitro-phenyl-b-d-galactopyranoside as a substrate
Electrophoretic mobility shift assay Double-stranded oligonucleotides containing the consensus sequence IRF-E site were radiolabeled with [32P]dCTP[aP]
at the 3¢ end with a Klenow fragment and then purified with a MicroSpin column (Amersham Biosciences, Piscata-way, NJ, USA) The sense sequences of the synthesized oligonucleotides used were as follows: for the native IRF-E site (GAACAGAAAGTGAAAG) in the human L-RAP 5¢-flanking region, and for mutation in the IRF-E site (GAACAGAGGGTGAGGG) and the antisense sequences
of synthesized oligonucleotides used were as follows: for native IRF-E site (TTTGCTTTCACTTTCT) in the human L-RAP 5¢-flanking region, for mutation in IRF-E site (TTTGCCCTCACCCTCT) The mutated nucleotide sequ-ences are underlined
Nuclear extracts of the cells were prepared as follows: the cells suspended in 500 lL of ice-cold buffer A [10 mm He-pes, 10 mm KCl, 1.5 mm MgCl2, 0.5 mm dithiothreitol (DTT), 0.2 mm phenylmethanesulfonyl fluoride (PMSF):
pH 7.9] were lysed in a Dounce-homogenizer and then the nuclei were pelleted by centrifugation at 3300 g for 15 min The pellets were then suspended in an equal volume of low salt buffer (20 mm Hepes, 20 mm KCl, 1.5 mm MgCl2, 0.2 mm EDTA, 0.5 mm DTT, 0.2 mm PMSF, 25% glycerol:
pH 7.9) Thereafter, half volume of high salt buffer (20 mm Hepes, 1.4 m KCl, 1.5 mm MgCl2, 0.2 mm EDTA, 0.5 mm DTT, 0.2 mm PMSF, 25% glycerol: pH 7.9) was added